FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)

View source ↗

Summary

FDA approved a supplemental labeling application for AUVI-Q (epinephrine auto-injector) submitted by Kaleo, Inc., resulting in updated product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis

Drugs mentioned

• AUVI-Q (Epinephrine)

Snippet

SUPPL AP for AUVI-Q (EPINEPHRINE)